Form 4 Tracker
Michael Raab

Director; Director, President & CEO · 10 filings · Latest: Jun 15, 2026

AMICUS THERAPEUTICS, INC.
ARDELYX, INC.
Tempest Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ARDX
Michael RaabDirector, President & CEOJun 15, 2026
Sale
$5.6741,666$236.3K1,699,200
ARDX
Michael RaabDirector, President & CEOJun 15, 2026
Option Exercise
$0.9920,833$20.6K1,740,866
ARDX
RAAB MICHAELJun 15, 2026
Proposed Sale
$5.6841,666$236.7K
ARDX
MICHAEL RAABJun 15, 2026
Proposed Sale
$5.69125,000$711.3K
ARDX
Michael RaabDirector, President & CEOMay 21, 2026
Sale
$6.2754,748$343.1K1,720,033
ARDX
RAAB MICHAELMay 19, 2026
Proposed Sale
$6.2344,500$277.2K
ARDX
Michael RaabDirector, President & CEOMay 15, 2026
Sale
$6.2841,666$261.6K1,774,781
ARDX
Michael RaabDirector, President & CEOMay 15, 2026
Option Exercise
$0.9920,833$20.6K1,816,447
ARDX
Michael RaabDirector, President & CEOApr 15, 2026
Sale
$6.2941,668$262.0K1,795,614
ARDX
Michael RaabDirector, President & CEOApr 15, 2026
Option Exercise
$0.9920,834$20.6K1,837,282
ARDX
Michael RaabDirector, President & CEOMar 16, 2026
Sale
$5.8441,666$243.3K1,816,448
ARDX
Michael RaabDirector, President & CEOMar 16, 2026
Option Exercise
$0.9920,833$20.6K1,856,986
ARDX
Michael RaabDirector, President & CEOFeb 24, 2026
Sale
$6.2641,666$260.6K1,836,153
ARDX
Michael RaabDirector, President & CEOFeb 24, 2026
Option Exercise
$0.9920,833$20.6K1,877,819
ARDX
MICHAEL RAABFeb 24, 2026
Proposed Sale
$5.75166,666$958.3K
ARDX
Michael RaabDirector, President & CEOFeb 20, 2026
Sale
$5.8545,982$268.8K1,856,986
ARDX
RAAB MICHAELFeb 20, 2026
Proposed Sale
$5.7351,100$292.8K
ARDX
RAAB MICHAELNov 20, 2025
Proposed Sale
$5.9145,868$271.1K
ARDX
MICHAEL RAABMay 2, 2025
Proposed Sale
$5.47125,000$683.8K
ARDX
MICHAEL RAABJan 7, 2025
Proposed Sale
$5.00166,666$833.3K

Page 1 of 2

Next →